These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Genotypic characterization of a nosocomial outbreak of VanA Enterococcus faecalis. Biavasco F; Miele A; Vignaroli C; Manso E; Lupidi R; Varaldo PE Microb Drug Resist; 1996; 2(2):231-7. PubMed ID: 9158765 [TBL] [Abstract][Full Text] [Related]
4. Glycopeptide-resistant enterococci: a decade of experience. Woodford N J Med Microbiol; 1998 Oct; 47(10):849-62. PubMed ID: 9788808 [TBL] [Abstract][Full Text] [Related]
5. Molecular epidemiology and antibiotic susceptibility of enterococci in Cincinnati, Ohio: a prospective citywide survey. Perlada DE; Smulian AG; Cushion MT J Clin Microbiol; 1997 Sep; 35(9):2342-7. PubMed ID: 9276414 [TBL] [Abstract][Full Text] [Related]
6. Vancomycin-resistant enterococci (VRE) colonization of high-risk patients in tertiary care Canadian hospitals. Canadian VRE Surveillance Group. Karlowsky JA; Zhanel GG; Hoban DJ Diagn Microbiol Infect Dis; 1999 Sep; 35(1):1-7. PubMed ID: 10529874 [TBL] [Abstract][Full Text] [Related]
7. European Glycopeptide Susceptibility Survey of gram-positive bacteria for 1995. European Glycopeptide Resistance Survey Study Group. Felmingham D; Brown DF; Soussy CJ Diagn Microbiol Infect Dis; 1998 Aug; 31(4):563-71. PubMed ID: 9764397 [TBL] [Abstract][Full Text] [Related]
8. Characterization of glycopeptide-resistant enterococci from a Swiss hospital. Liassine N; Frei R; Jan I; Auckenthaler R J Clin Microbiol; 1998 Jul; 36(7):1853-8. PubMed ID: 9650924 [TBL] [Abstract][Full Text] [Related]
9. Proficiency of Italian clinical laboratories in detecting reduced glycopeptide susceptibility in Enterococcus and Staphylococcus spp. using routine laboratory methodologies. Jones ME; Gesu G; Ortisi G; Sahm DF; Critchley IA; Goglio A; Clin Microbiol Infect; 2002 Feb; 8(2):101-11. PubMed ID: 11952723 [TBL] [Abstract][Full Text] [Related]
10. Emergence of vancomycin-resistant enterococci in Australia: phenotypic and genotypic characteristics of isolates. Bell JM; Paton JC; Turnidge J J Clin Microbiol; 1998 Aug; 36(8):2187-90. PubMed ID: 9665988 [TBL] [Abstract][Full Text] [Related]
11. [Molecular characterization of vancomycin-resistant enterococci isolates]. Liu YM; Cao B; Wang H; Li BB; Yang CX; Wang QT; Du XL; Li F; Wang SS; Qu SS Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(11):760-3. PubMed ID: 18683685 [TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibility studies and detection of vancomycin resistance genes in clinical isolates of enterococci in Nagasaki, Japan. Hirakata Y; Yamaguchi T; Izumikawa K; Matsuda J; Tomono K; Kaku M; Koga H; Yamada Y; Kohno S; Kamihira S Epidemiol Infect; 1997 Oct; 119(2):175-81. PubMed ID: 9363016 [TBL] [Abstract][Full Text] [Related]
13. [A 6-year study of glycopeptides-resistant enterococci in 3 intensive care units of the University Hospital of Montpellier]. Godreuil S; Marchandin H; Boulier A; Boumzebra A; Campos J; Jean-Pierre H Pathol Biol (Paris); 2007 Nov; 55(8-9):418-23. PubMed ID: 17905540 [TBL] [Abstract][Full Text] [Related]
14. Species, antibiotic susceptibility profiles and van gene frequencies among enterococci isolated from patients at Mulago National Referral Hospital in Kampala, Uganda. Kateete DP; Edolu M; Kigozi E; Kisukye J; Baluku H; Mwiine FN; Najjuka CF BMC Infect Dis; 2019 May; 19(1):486. PubMed ID: 31151413 [TBL] [Abstract][Full Text] [Related]
15. Emergence of High-level Gentamicin Resistance among Labibzadeh M; Kaydani GA; Savari M; Ekrami A Pol J Microbiol; 2018; 67(4):401-406. PubMed ID: 30550226 [TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of glycopeptide-resistant enterococci from hospitalized patients over a 30-month period. Nelson RR; McGregor KF; Brown AR; Amyes SG; Young H J Clin Microbiol; 2000 Jun; 38(6):2112-6. PubMed ID: 10834962 [TBL] [Abstract][Full Text] [Related]
17. Prevalence and antimicrobial resistance pattern of multidrug-resistant enterococci isolated from clinical specimens. Salem-Bekhit MM; Moussa IM; Muharram MM; Alanazy FK; Hefni HM Indian J Med Microbiol; 2012; 30(1):44-51. PubMed ID: 22361760 [TBL] [Abstract][Full Text] [Related]
18. In vitro activity of daptomycin against vancomycin-resistant enterococci of various Van types and comparison of susceptibility testing methods. Jorgensen JH; Crawford SA; Kelly CC; Patterson JE Antimicrob Agents Chemother; 2003 Dec; 47(12):3760-3. PubMed ID: 14638478 [TBL] [Abstract][Full Text] [Related]
20. Role of transposon Tn5482 in the epidemiology of vancomycin-resistant Enterococcus faecium in the pediatric oncology unit of a New York City Hospital. de Lencastre H; Brown AE; Chung M; Armstrong D; Tomasz A Microb Drug Resist; 1999; 5(2):113-29. PubMed ID: 10432272 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]